Boris Acevedo

1.2k total citations
25 papers, 682 citations indexed

About

Boris Acevedo is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Boris Acevedo has authored 25 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Boris Acevedo's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Biotechnology and Related Fields (3 papers). Boris Acevedo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Biotechnology and Related Fields (3 papers). Boris Acevedo collaborates with scholars based in Cuba, Argentina and Thailand. Boris Acevedo's co-authors include Jorge Gavilondo, Yasser Perera, Daniel F. Alonso, Silvio E. Perea, Osvaldo Reyes, Marta Ayala, Gertrudis Rojas, Roberto Gómez, Isis Torréns and Ernesto López‐Morales and has published in prestigious journals such as Cancer Research, FEBS Letters and International Journal of Cancer.

In The Last Decade

Boris Acevedo

24 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boris Acevedo Cuba	16	446	80	79	74	67	25	682
Lyudmila V. Savvateeva Russia	13	229 0.5×	108 1.4×	101 1.3×	18 0.2×	50 0.7×	32	499
Samuel J. S. Rubin United States	15	365 0.8×	160 2.0×	232 2.9×	60 0.8×	98 1.5×	31	823
Kristina Oresic Bender United States	7	240 0.5×	73 0.9×	43 0.5×	33 0.4×	38 0.6×	8	451
Sandra Carvalho Portugal	17	687 1.5×	227 2.8×	376 4.8×	60 0.8×	35 0.5×	21	1.2k
Scott Cooper United States	13	656 1.5×	160 2.0×	173 2.2×	55 0.7×	38 0.6×	13	1.1k
Yongdong Liu China	17	345 0.8×	131 1.6×	158 2.0×	63 0.9×	123 1.8×	64	882
Mark B. Jones United States	17	816 1.8×	101 1.3×	374 4.7×	221 3.0×	72 1.1×	29	1.1k
Glenn N. Major United Kingdom	14	280 0.6×	42 0.5×	38 0.5×	67 0.9×	92 1.4×	22	508
Hailong Xie China	17	340 0.8×	95 1.2×	92 1.2×	21 0.3×	36 0.5×	45	637
Christian Jöst Switzerland	18	582 1.3×	352 4.4×	107 1.4×	273 3.7×	106 1.6×	32	1.1k

Countries citing papers authored by Boris Acevedo

Since Specialization

Citations

This map shows the geographic impact of Boris Acevedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Acevedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Acevedo more than expected).

Fields of papers citing papers by Boris Acevedo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Acevedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Acevedo. The network helps show where Boris Acevedo may publish in the future.

Co-authorship network of co-authors of Boris Acevedo

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Acevedo. A scholar is included among the top collaborators of Boris Acevedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Acevedo. Boris Acevedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berlanga, Jorge, Ernesto López‐Morales, Pedro Benito López, et al.. (2013). Heberprot-P: A Novel Product for Treating Advanced Diabetic Foot Ulcer. MEDICC Review. 15(1). 11–11. 20 indexed citations

Berlanga, Jorge, Ernesto López‐Morales, Carmen Valenzuela, et al.. (2013). Heberprot-P: a novel product for treating advanced diabetic foot ulcer. MEDICC Review. 15(1). 11–15. 43 indexed citations

Perera, Yasser, Osvaldo Reyes, Hernán G. Fariña, et al.. (2012). Sensitivity of tumor cells towards CIGB‐300 anticancer peptide relies on its nucleolar localization. Journal of Peptide Science. 18(4). 215–223. 22 indexed citations

Perera, Yasser, Hernán G. Fariña, Jeovanis Gil, et al.. (2009). Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Molecular Cancer Therapeutics. 8(5). 1189–1196. 47 indexed citations

Vallespí, Maribel Guerra, Julio R. Fernández, Isis Torréns, et al.. (2009). Identification of a novel antitumor peptide based on the screening of an Ala‐library derived from the LALF_32–51 region. Journal of Peptide Science. 16(1). 40–47. 18 indexed citations

Castellanos, Marlén, Sergio Ojeda, Santiago Dueñas‐Carrera, et al.. (2009). Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti‐hepatitis B vaccination. The Journal of Gene Medicine. 12(1). 107–116. 19 indexed citations

Baladrón, Idania, Carmen Valenzuela, Carlos A. González, et al.. (2009). Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies. BMC Cancer. 9(1). 146–146. 51 indexed citations

Acevedo, Boris, et al.. (2008). Desarrollo, validación y registro del sistema HeberFast Line® antitransglutaminasa. Contribución al diagnóstico de la enfermedad celiaca en Cuba. Biotecnología aplicada. 25(1). 62–65.

Béquet‐Romero, Mónica, Marta Ayala, Boris Acevedo, et al.. (2007). Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice. Angiogenesis. 10(1). 23–34. 19 indexed citations

10.

Perera, Yasser, Hernán G. Fariña, Ignacio Hernández, et al.. (2007). Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice. International Journal of Cancer. 122(1). 57–62. 48 indexed citations

11.

Acevedo, Boris, et al.. (2006). Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma. The Prostate. 66(10). 1029–1036. 12 indexed citations

12.

Silva, Ricardo, et al.. (2006). Biotechnology in Cuba: 20 years of scientific, social and economic progress. Journal of Commercial Biotechnology. 13(1). 1–11. 10 indexed citations

13.

Rábano, Alberto, Adolfo Jiménez‐Huete, Boris Acevedo, et al.. (2005). Diversity of Senile Plaques in Alzheimers Disease as Revealed by a New Monoclonal Antibody that Recognizes an Internal Sequence of the Aβ Peptide. Current Alzheimer Research. 2(4). 409–417. 5 indexed citations

14.

Ayala, Marta, et al.. (2005). A multivalent recombinant antibody fragment specific for carcinoembryonic antigen. Biotechnology and Applied Biochemistry. 43(1). 39–48. 15 indexed citations

15.

Perea, Silvio E., Osvaldo Reyes, Nelson Santiago Vispo, et al.. (2004). Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2). Cancer Research. 64(19). 7127–7129. 117 indexed citations

16.

Acevedo, Boris, et al.. (2002). Purification of the recombinant hepatitis B core antigen, and its potential use for the diagnosis of hepatitis B virus infection. Biotecnología aplicada. 19. 138–142. 5 indexed citations

17.

Rojas, Gertrudis, Juan C. Almagro, Boris Acevedo, & Jorge Gavilondo. (2002). Phage antibody fragments library combining a single human light chain variable region with immune mouse heavy chain variable regions. Journal of Biotechnology. 94(3). 287–298. 19 indexed citations

18.

Acevedo, Boris, et al.. (2002). Development and validation of a quantitative ELISA for the measurement of PSA concentration. Clinica Chimica Acta. 317(1-2). 55–63. 91 indexed citations

19.

Sorell, Luis, Juan Antonio López, Israel Valdés, et al.. (1998). An innovative sandwich ELISA system based on an antibody cocktail for gluten analysis. FEBS Letters. 439(1-2). 46–50. 60 indexed citations

20.

Camafeita, Emilio, Patricia Alfonso, Boris Acevedo, & Enrique Méndez. (1997). Sample Preparation Optimization for the Analysis of Gliadins in Food by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry. Journal of Mass Spectrometry. 32(4). 444–449. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact